Analysts Issue Forecasts for Humacyte FY2026 Earnings
Humacyte, Inc. (NASDAQ:HUMA – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Humacyte in a report released on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the company will post earnings per share of ($0.49) for the year. The consensus estimate for Humacyte’s current full-year earnings is […]
